Rudiger, A., Breitenstein, A., Arrigo, M., Salzberg, S. P., & Bettex, D. (2014). Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation.
Citação norma ChicagoRudiger, Alain, Alexander Breitenstein, Mattia Arrigo, Sacha P. Salzberg, and Dominique Bettex. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
ציטוט MLARudiger, Alain, et al. Suitability, Efficacy, and Safety of Vernakalant for New Onset Atrial Fibrillation in Critically Ill Patients. Hindawi Publishing Corporation, 2014.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.